The North America laboratory informatics market was valued at USD 1629.30 Million in 2024, driven by the accelerating demand for cloud-based laboratory informatics platforms across the region. The market is anticipated to grow at a CAGR of 4.30% during the forecast period of 2025-2034 to achieve a value of USD 2482.24 Million by 2034.
Base Year
Historical Year
Forecast Year
The market is expected to grow significantly due to the rising adoption of artificial intelligence, automation, and cloud-based solutions, enhancing data management, regulatory compliance, and laboratory efficiency across industries.
Increasing investments in biotechnology, pharmaceuticals, and clinical research are driving demand for advanced laboratory information management systems (LIMS) and electronic lab notebooks (ELN) systems, enabling seamless workflow integration, real-time collaboration, and enhanced decision-making for research and diagnostics.
Strategic partnerships between informatics providers and scientific organisations are accelerating innovation, fostering next-generation laboratory technologies, and improving data security, interoperability, and automation to meet evolving regulatory and research demands.
Value in USD Million
2025-2034
North America Laboratory Informatics Market Outlook
*this image is indicative*
Laboratory informatics refers to the application of information technology (IT) and software solutions to manage, process, and analyse laboratory data efficiently. It includes Laboratory Information Management Systems (LIMS), Electronic Lab Notebooks (ELN), Scientific Data Management Systems (SDMS), and Chromatography Data Systems (CDS). These solutions enhance data accuracy, compliance, workflow automation, and collaboration across industries like pharmaceuticals, biotechnology, clinical diagnostics, and chemical research. With advancements in cloud computing, AI, and automation, laboratory informatics is transforming data-driven decision-making, improving research efficiency, regulatory compliance, and laboratory productivity in modern scientific environments.
Adoption of Unified Digital Platforms to Drive Market Growth
The increasing demand for integrated lab management solutions and the growing adoption of cloud-based LIMS and ELN platforms are key drivers of the market. For instance , in October 2024, eLabNext rebranded its three key products eLabJournal, eLabInventory, and eLabProtocols into a single, centralised Digital Lab Platform (DLP), combining LIMS and ELN functionalities. This transition enhances data security, efficiency, and research collaboration, aligning with the market’s shift towards streamlined laboratory management. As laboratories prioritise consolidated informatics solutions, such innovations will accelerate LIMS adoption, digital transformation, and market expansion in North America.
Preference for Advanced ELN Systems to Impact North America Laboratory Informatics Market Size Positively
The rising need for efficient data management and workflow automation is propelling the growth of laboratory informatics in North America. For instance, in December 2024, TeselaGen Biotechnology, a biotechnology software leader launched an advanced Electronic Lab Notebook (ELN), featuring a unified user interface for enhanced usability and collaboration. This ELN integrates workflow tools, real-time data sharing, and research-driven functionalities, enabling scientists to record, organise, and analyse experimental data seamlessly. By improving laboratory productivity and standardising data management, this innovation will boost ELN adoption, further driving the expansion of digital informatics solutions in biotech and pharmaceutical research.
Surge in Global Collaborations to Strengthen the North America Laboratory Informatics Market Value
The increasing globalisation of biopharmaceutical research and the rising need for cross-border laboratory collaborations are shaping the market. For instance, in June 2024, LabWare, a leading Laboratory Information Management Systems (LIMS) provider participated in an exploratory delegation to Ireland, engaging with biopharma organisations, research institutions, and economic development entities. This initiative facilitated knowledge exchange, innovation partnerships, and insights into biopharmaceutical manufacturing advancements. By strengthening international collaborations and fostering cutting-edge laboratory technologies, such efforts are expected to accelerate LIMS adoption, enhancing data-driven decision-making and compliance across pharmaceutical and biotech industries.
Rising AI and Automation Integration to Elevate North America Laboratory Informatics Market Demand
The rising demand for AI-driven automation and data standardisation in laboratories is a key factor driving market expansion. For instance, in June 2024, multiple research foundations funded early-career scientists to advance automated chemical laboratories, focusing on AI integration and intelligent instrumentation. This initiative aims to accelerate innovation and improve accessibility within laboratory informatics. By supporting cutting-edge automation, such funding is poised to enhance laboratory efficiency, reduce manual errors, and boost adoption of intelligent LIMS and ELN systems, driving the long-term growth of the market.
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
North America Laboratory Informatics Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Product
Market Breakup by Delivery Mode
Market Breakup by Component
Market Breakup by End User
Market Breakup by Country
Laboratory Information Management Systems (LIMS) to Lead the Segmentation by Product
LIMS is poised to dominate the market due to its critical role in sample management, regulatory compliance, and workflow automation. The growing need for efficient data tracking and integration in research and diagnostics has made LIMS indispensable across industries. Advances in AI-driven analytics and cloud-based capabilities further enhance its functionality and scalability. As laboratories increasingly prioritise operational efficiency and data security, LIMS adoption is set to surge, driven by its ability to streamline laboratory processes, ensure regulatory adherence, and enhance research productivity in the biotech, pharmaceutical, and clinical sectors.
Cloud-based Solutions to Dominate the North America Laboratory Informatics Market Segmentation by Delivery Mode
Cloud-based laboratory informatics solutions are set to lead due to rising demand for scalability, remote accessibility, and cost-effectiveness. Laboratories are shifting from on-premise systems to cloud-hosted platforms to enable real-time data sharing, seamless integrations, and AI-driven automation. As per the analysis by Expert Market Research, the global healthcare cloud computing market is projected to expand at a CAGR of 16.80% from 2025 to 2034. The flexibility of cloud-based solutions allows businesses to scale operations while reducing infrastructure costs, making it highly attractive for pharmaceutical, biotech, and research organisations. Additionally, advancements in cybersecurity and regulatory compliance are fostering wider adoption, ensuring data integrity and security. With laboratories increasingly adopting digital transformation strategies, cloud-based informatics will be a key driver of market expansion.
Software to Hold a Significant North America Laboratory Informatics Market Value for Segmentation by Component
The software segment is expected to dominate the market, driven by continuous advancements in AI, automation, and cloud-based LIMS platforms. The increasing need for data standardisation, interoperability, and enhanced analytics across biotech, pharmaceutical, and diagnostic laboratories is propelling demand. Modern informatics software enables seamless data integration, regulatory compliance, and efficient laboratory workflows, making it a core investment for research institutions. With the rapid evolution of scientific computing, AI-powered automation, and SaaS-based solutions, the software segment will continue to drive market growth, shaping the future of laboratory efficiency and innovation.
Pharmaceutical Companies to Dominating the North America Laboratory Informatics Market Share by End User
Pharmaceutical companies are set to hold the largest share in the North America laboratory informatics market, primarily due to stringent regulatory requirements, increasing R&D investments, and the need for efficient drug development processes. The adoption of LIMS, ELN, and AI-powered analytics is enhancing research productivity, compliance, and data security. With growing demand for precision medicine, biologics, and clinical trials, pharmaceutical firms are rapidly integrating digital informatics solutions to streamline operations. As industry regulations tighten and the demand for efficient drug discovery accelerates, laboratory informatics solutions will remain crucial in driving innovation, efficiency, and market expansion.
North America Laboratory Informatics Market Analysis by Region
The United States is expected to dominate the market, driven by extensive R&D investments, a well-established biotech and pharmaceutical industry, and increasing laboratory digitalisation. The presence of key market players, stringent regulatory requirements, and rising adoption of AI-driven informatics solutions further accelerates growth. Meanwhile, Canada is witnessing steady expansion due to growing government initiatives, investments in precision medicine, and the adoption of cloud-based LIMS. As laboratories prioritise automation, compliance, and efficiency, both countries are fostering advancements in data management, cybersecurity, and AI-powered laboratory solutions, shaping the region’s informatics market landscape.
The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Founded in 1966 and headquartered in Pune, India, Serum Institute of India is the world's largest vaccine manufacturer by volume. The company specialises in developing and producing affordable vaccines for infectious diseases such as measles, polio, diphtheria, and COVID-19. It played a crucial role in global immunisation efforts with its Covishield (AstraZeneca’s COVID-19 vaccine). With a strong focus on biotechnology research and global vaccine distribution, Serum Institute supplies vaccines to over 170 countries, supporting public health initiatives through cost-effective and high-quality vaccine production.
Established in 1916 and headquartered in Melbourne, Australia, CSL Limited is a global biotechnology leader specialising in innovative biopharmaceuticals, vaccines, and plasma-derived therapies. Its subsidiaries, CSL Behring and Seqirus, focus on rare and serious diseases, immunoglobulin therapies, and influenza vaccines. CSL is at the forefront of plasma protein research, gene therapy, and recombinant protein development. With operations spanning over 35 countries, it plays a significant role in global healthcare advancements, particularly in immunology, haematology, and respiratory diseases, contributing to life-saving treatments worldwide.
Founded in 1996 and headquartered in Hyderabad, India, Bharat Biotech is a pioneering biotechnology company specialising in vaccine development and biopharmaceutical innovation. It is renowned for producing Covaxin, India’s first indigenous COVID-19 vaccine, alongside vaccines for rotavirus, typhoid, hepatitis, and chikungunya. The company emphasises cutting-edge research, in-house manufacturing, and global collaborations to address infectious diseases. With a strong commitment to public health and affordable immunisation solutions, Bharat Biotech continues to expand its R&D capabilities, contributing to global vaccine accessibility and pandemic preparedness.
Established in 2009 and headquartered in Tianjin, China, CanSino Biologics is a leading biopharmaceutical company specialising in vaccine research and development. It gained international recognition for developing Convidecia, a single-dose COVID-19 vaccine. The company’s portfolio includes vaccines for meningitis, tuberculosis, and Ebola, with a strong emphasis on innovative delivery systems, including viral vector and mRNA platforms. CanSino’s focus on high-quality, scalable vaccine production positions it as a key player in global immunisation efforts, particularly in emerging infectious diseases and pandemic response strategies.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Sinovac Biotech, SK Bioscience, Daiichi Sankyo, Biological E. Limited, Hualan Biological Engineering Inc., and PT Bio Farma.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Delivery Mode |
|
| Breakup by Component |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 2,699
USD 2,429
tax inclusive*
Single User License
One User
USD 4,299
USD 3,869
tax inclusive*
Five User License
Five User
USD 5,799
USD 4,949
tax inclusive*
Corporate License
Unlimited Users
USD 6,999
USD 5,949
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share